Конкурс уже в третий раз проводят Фонд «Сколково» и международная биофармацевтическая компания «АстраЗенека». Особенностью состязания этого года стало то, что все этапы, включая двухдневный финал, проходят онлайн 30 июня определятся...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
UNIM , a resident startup of the Skolkovo Foundation’s biomed cluster that provides remote cancer diagnosis services, has raised investment from Medme, a strategic investor on the digital medicine market. Under the terms of the deal, the details of which...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
The Skolkovo Foundation announced the official launch of Skolkovo Ventures – three new investment funds devoted to IT, industrial technology and biotech – at the Startup Village open-air conference on Tuesday. The investment funds have been set...